ERBB2 and cancer: Simultaneously, HER2-overexpressing cancer cells activate HSF1 via the PI3K-AKT axis by phosphorylation of HSF1 at Ser326 followed by the stabilization of tumor-promoting proteins perceived as HSP90 clients 111.